COMPLEXT PATIENT DERIVED ORGANOIDS(CPDOS) MODELING FOR ANTI-CANCER DRUG SCREENING

被引：0
|
作者：
Li, Ling
Knutsdottir, Hildur
Hui, Ken
Weiss, Matthew J.
He, Jin
Philosophe, Benjamin
Cameron, Andrew
Wolfgang, Christopher L.
Pawlik, Timothy M.
Ghiaur, Gabriel
Ewald, Andrew
Mezey, Esteban
Bader, Joel
Selaru, Florin
机构：
来源：
GASTROENTEROLOGY | 2019年 / 156卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
490e
引用
收藏
页码：S1508 / S1508
页数：1
相关论文
共 50 条
  • [21] Microfluidics: Emerging prospects for anti-cancer drug screening
    Wlodkowic, Donald
    Darzynkiewicz, Zbigniew
    WORLD JOURNAL OF CLINICAL ONCOLOGY, 2010, 1 (01): : 18 - 23
  • [22] Patient-Derived Organoids as a Model for Cancer Drug Discovery
    Rae, Colin
    Amato, Francesco
    Braconi, Chiara
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (07)
  • [23] Ductal pancreatic cancer modeling and drug screening using human pluripotent stem cell- and patient-derived tumor organoids
    Huang, Ling
    Holtzinger, Audrey
    Jagan, Ishaan
    BeGora, Michael
    Lohse, Ines
    Ngai, Nicholas
    Nostro, Cristina
    Wang, Rennian
    Muthuswamy, Lakshmi B.
    Crawford, Howard C.
    Arrowsmith, Cheryl
    Kalloger, Steve E.
    Renouf, Daniel J.
    Connor, Ashton A.
    Cleary, Sean
    Schaeffer, David F.
    Roehrl, Michael
    Tsao, Ming-Sound
    Gallinger, Steven
    Keller, Gordon
    Muthuswamy, Senthil K.
    NATURE MEDICINE, 2015, 21 (11) : 1364 - 1371
  • [24] Selective colony area method for heterogeneous patient-derived tumor cell lines in anti-cancer drug screening system
    Cho, Jang
    Kim, Ju-Sun
    Kim, Seung
    Hong, Jung
    Park, Joon
    Park, Young
    Nam, Do-Hyun
    Lee, Dong
    Lee, Jeeyun
    PLOS ONE, 2019, 14 (04):
  • [25] PERSONALIZED DRUG SCREENING IN PATIENT-DERIVED ORGANOIDS OF BILIARY TRACT CANCER AND ITS CLINICAL APPLICATION
    Ren, Xiaoxue
    Wu, Yifan
    Huang, Mingle
    Li, Xiaoxing
    Yu, Jun
    Xu, Lixia
    GASTROENTEROLOGY, 2023, 164 (06) : S1255 - S1255
  • [26] Personalized drug screening in patient-derived organoids of biliary tract cancer and its clinical application
    Ren, Xiaoxue
    Huang, Mingle
    Weng, Weixiang
    Xie, Yubin
    Wu, Yifan
    Zhu, Shenghua
    Zhang, Ying
    Li, Dongming
    Lai, Jiaming
    Shen, Shunli
    Lin, Jie
    Kuang, Ming
    Li, Xiaoxing
    Yu, Jun
    Xu, Lixia
    CELL REPORTS MEDICINE, 2023, 4 (11)
  • [27] Patient-derived organoids of non-small cells lung cancer and their application for drug screening
    Li, Y. F.
    Gao, Y.
    Liang, B. W.
    Cao, X. Q.
    Sun, Z. J.
    Yu, J. H.
    Liu, Z. D.
    Han, Y.
    NEOPLASMA, 2020, 67 (02) : 430 - +
  • [28] Establishment of patient derived organoids from resected primary lung cancer as an in vitro model for drug screening
    Koga, Takamasa
    ANNALS OF ONCOLOGY, 2021, 32 : S306 - S306
  • [29] Molecular Modeling Applied to Anti-Cancer Drug Development
    Rosales-Hernandez, M. C.
    Bermudez-Lugo, J.
    Garcia, Jazmin
    Trujillo-Ferrara, J.
    Correa-Basurto, J.
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2009, 9 (02) : 230 - 238
  • [30] Black patient representation in anti-cancer drug development
    Karol, Alexander B.
    Paredes, Rodrigo
    Fujiwara, Yu
    Argulian, Anna
    Joshi, Himanshu
    Galsky, Matt D.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
12345